Scarica l'app Stockscreener
61.18
1.24%
0.75
Pre-mercato:
60.63
-0.55
-0.90%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DXCM Giù?
Forum
Previsione
Frazionamento azionario
Dexcom Inc Borsa (DXCM) Ultime notizie
DEXCOM CLASS ACTION LAWSUIT: DexCom, Inc. (NASDAQ:DXCM) - GlobeNewswire
Building trade automation scripts for DexCom Inc.M&A Rumor & Growth Oriented Trade Recommendations - newser.com
Can DexCom Inc. stock maintain operating margins2025 Trading Volume Trends & Fast Gain Stock Trading Tips - newser.com
Will breakout in DexCom Inc. lead to full recoveryMarket Performance Summary & Accurate Trade Setup Notifications - newser.com
DexCom Inc. stock outlook for YEARIndex Update & Weekly Stock Performance Updates - newser.com
Lost Money on DexCom, Inc. (DXCM)? Contact Levi & Korsinsky to Join Class Action Before December 26, 2025 - ACCESS Newswire
What catalysts could drive DexCom Inc. stock higherPortfolio Value Report & Daily Stock Momentum Reports - newser.com
Is DexCom Inc. (DC4) stock a top pick for value investorsSell Signal & Fast Exit and Entry Strategy Plans - newser.com
Is DexCom Inc. (DC4) stock supported by free cash flow2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Join Class Action to Recover Losses from DexCom, Inc. (DXCM)Contact Levi & Korsinsky Before December 26, 2025 - ACCESS Newswire
Stockholder Alert: Robbins LLP Informs Investors of the Dexcom, Inc. Class Action Lawsuit - Your Wyoming Link
Levi & Korsinsky Moves to SueWallSt for DexCom, Inc. Investors That Lost Money - ACCESS Newswire
DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. InvestorsLead Plaintiff Deadline December 26, 2025 - ACCESS Newswire
DexCom (NASDAQ:DXCM) Price Target Lowered to $95.00 at UBS Group - MarketBeat
Securities Fraud Class Action Filed Against DexCom, Inc. (DXCM)Levi & Korsinsky Reminds Investors of December 26, 2025 - ACCESS Newswire
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
ROSEN, A LEADING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important ... - Bluefield Daily Telegraph
ROSEN, A LEADING LAW FIRM, Encourages DexCom, Inc. - GlobeNewswire
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Dexcom recalls G6 CGM app over software problem - MedTech Dive
DexCom (NASDAQ:DXCM) Given "Buy" Rating at Truist Financial - MarketBeat
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Is DexCom Inc. (DC4) stock cheap by valuation metricsMarket Risk Summary & Community Consensus Picks - newser.com
Can DexCom Inc. (DC4) stock hit consensus price targetsPortfolio Growth Summary & Weekly Top Gainers Alerts - newser.com
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - MarketScreener
Freestone Capital Holdings LLC Purchases 7,242 Shares of DexCom, Inc. $DXCM - MarketBeat
What MACD and RSI say about DexCom Inc.CEO Change & Smart Money Movement Alerts - newser.com
DexCom, Inc. Hits New 52-Week Low at $56.45 Amid Market Struggles - Markets Mojo
Has DexCom Inc. found a price floor2025 Big Picture & Real-Time Volume Surge Alerts - newser.com
Will DexCom Inc. stock continue dividend increasesDollar Strength & Verified Chart Pattern Trade Signals - newser.com
DexCom, Inc. Experiences Valuation Adjustment Amidst Competitive Market Dynamics - Markets Mojo
Can technical indicators confirm DexCom Inc.’s reversalEarnings Recap Summary & Proven Capital Preservation Methods - newser.com
DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Securities Class Action Lawsuit Filed Against DexCom, Inc. (DXCM)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Is DexCom Inc. (DC4) stock a buy for dividend portfoliosPrice Action & Safe Investment Capital Preservation Plans - newser.com
Lost Money on DexCom, Inc. (DXCM)? Urged to Join Class Action Before December 26, 2025Contact Levi & Korsinsky - ACCESS Newswire
DexCom (DXCM): UBS Lowers Price Target to $95, Maintains 'Buy' R - GuruFocus
DexCom Faces Class Action Over Alleged Investor Deception - TipRanks
DXCM CLASS ACTION LAWSUIT: A Securities Fraud Class Action - GlobeNewswire
DexCom Stock Rises 3.7% on November 3, 2025 | DXCM NewsNews and Statistics - IndexBox
DexCom (DXCM) Stock Is Up, What You Need To Know - TradingView
DexCom Growth Outlook Likely Sustainable, UBS Says - MarketScreener
UBS Adjusts DexCom Price Target to $95 From $106, Maintains Buy Rating - MarketScreener
Truist Securities Reiterates Buy Rating on DexCom (DXCM) Despite - GuruFocus
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Statistical indicators supporting DexCom Inc.’s strengthM&A Rumor & Safe Entry Zone Identification - newser.com
AlphaQuest LLC Sells 4,660 Shares of DexCom, Inc. $DXCM - Defense World
Will DexCom Inc. stock maintain momentum in 2025Inflation Watch & Weekly Momentum Stock Picks - newser.com
What does recent volatility data suggest for DexCom Inc.2025 Big Picture & Verified Entry Point Signals - newser.com
Is DexCom Inc. stock reversal real or fakeQuarterly Investment Review & Daily Stock Trend Reports - newser.com
FY2025 EPS Estimates for DexCom Increased by Leerink Partnrs - MarketBeat
What is William Blair's Forecast for DexCom FY2025 Earnings? - MarketBeat
1.91%
0.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):